[{"address1": "451 D Street", "address2": "5th Floor Suite 501", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "(857) 209-0050", "website": "https://elicio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node\u0096targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node\u0096targeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph node\u0096targeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert T. Connelly", "age": 64, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 943020, "exercisedValue": 0, "unexercisedValue": 137562}, {"maxAge": 1, "name": "Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.", "age": 77, "title": "Founder & Independent Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 48125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  DeMuth Ph.D.", "age": 37, "title": "Chief Scientific Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 648600, "exercisedValue": 0, "unexercisedValue": 54705}, {"maxAge": 1, "name": "Dr. Christopher M. Haqq M.D., Ph.D.", "age": 58, "title": "Executive VP, Head of Research & Development and Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 721087, "exercisedValue": 0, "unexercisedValue": 86025}, {"maxAge": 1, "name": "Dr. Darrell J. Irvine Ph.D.", "title": "Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preetam  Shah M.B.A., Ph.D.", "age": 51, "title": "Chief Strategy & Financial Officer and Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan C. Filoon", "title": "General Counsel, Secretary & Compliance Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Esther  Welkowsky", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joy  Seymour", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thian  Kheoh Ph.D.", "title": "Senior Vice President of Biometrics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.02, "open": 5.24, "dayLow": 5.13, "dayHigh": 5.75, "regularMarketPreviousClose": 5.02, "regularMarketOpen": 5.24, "regularMarketDayLow": 5.13, "regularMarketDayHigh": 5.75, "payoutRatio": 0.0, "forwardPE": -2.1400778, "volume": 19242, "regularMarketVolume": 19242, "averageVolume": 40808, "averageVolume10days": 40890, "averageDailyVolume10Day": 40890, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 87744248, "fiftyTwoWeekLow": 3.342, "fiftyTwoWeekHigh": 11.45, "fiftyDayAverage": 6.6697, "twoHundredDayAverage": 5.680805, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 96086880, "profitMargins": 0.0, "floatShares": 10268426, "sharesOutstanding": 15953500, "sharesShort": 151823, "sharesShortPriorMonth": 170043, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0095, "heldPercentInsiders": 0.43480998, "heldPercentInstitutions": 0.071779996, "shortRatio": 3.19, "shortPercentOfFloat": 0.0148, "impliedSharesOutstanding": 16274500, "bookValue": -1.026, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -51898000, "trailingEps": -4.25, "forwardEps": -2.57, "lastSplitFactor": "1:10", "lastSplitDate": 1685664000, "enterpriseToEbitda": -2.151, "52WeekChange": -0.38752782, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 5.5, "targetHighPrice": 12.0, "targetLowPrice": 10.0, "targetMeanPrice": 11.0, "targetMedianPrice": 11.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 17618000, "totalCashPerShare": 1.105, "ebitda": -44665000, "totalDebt": 26040000, "quickRatio": 1.529, "currentRatio": 1.796, "returnOnAssets": -1.01642, "returnOnEquity": -1701.5737, "freeCashflow": -23701624, "operatingCashflow": -37068000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ELTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Elicio Therapeutics, Inc.", "longName": "Elicio Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "regularMarketChange": 0.48000002, "regularMarketDayRange": "5.13 - 5.75", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 40808, "fiftyTwoWeekLowChange": 2.158, "fiftyTwoWeekLowChangePercent": 0.64572114, "fiftyTwoWeekRange": "3.342 - 11.45", "fiftyTwoWeekHighChange": -5.95, "fiftyTwoWeekHighChangePercent": -0.51965064, "fiftyTwoWeekChangePercent": -38.75278, "earningsTimestamp": 1743418800, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.25, "epsForward": -2.57, "epsCurrentYear": -2.4, "priceEpsCurrentYear": -2.2916665, "corporateActions": [], "regularMarketTime": 1746216001, "exchange": "NCM", "messageBoardId": "finmb_214936128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 9.561753, "regularMarketPrice": 5.5, "marketState": "CLOSED", "fiftyDayAverageChange": -1.1697001, "fiftyDayAverageChangePercent": -0.17537522, "twoHundredDayAverageChange": -0.1808052, "twoHundredDayAverageChangePercent": -0.03182739, "priceToBook": -5.360624, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Angion Biomedica Corp.", "nameChangeDate": "2025-04-29", "cryptoTradeable": false, "displayName": "Elicio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]